The Identifying Information Law requires City agencies to submit comprehensive biennial agency reports (Form 3) related to their collection, disclosure, and retention of identifying information and their privacy protection practices.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.
Local Law 65 of 2019, requires the Department of Environmental Protection to make information about known lead water service lines available on the city's website, available via LeadFreeNYC.
To report on the progress made this quarter in implementing the plans as outlined in the Civil Service Commission's annual plan for Diversity and Inclusion in hiring and promotion for fiscal year 2022.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.